Skip to main content

Global Allergy Diagnostics Market to See 11% CAGR Backed by Healthcare Digitalization by 2030

 


The global allergy diagnostics market is set to witness a healthy growth rate of 11% in the next 5 years. Growing cases of allergic diseases (asthma, allergic rhinitis, atopic dermatitis, and food allergy), rising environmental pollution levels, high volume consumption of processed food and beverages, the advent of mHealth in allergy diagnosis & care and growing awareness about allergic diseases are some of the key factors driving the market.

Allergies are the body’s reaction to a substance it considers a harmful “invader.” Substances that cause these reactions are called allergens. An individual can be allergic to a wide variety of substances including pollen, food and drug, animal dander, moulds, insect venom, latex, and dust mites, among others. Allergic diseases are a global health problem that affects approximately 20-30% of the population in industrialized countries. The prevalence of allergic diseases globally has continued to grow in the industrialized world for more than 50 years. Allergic diseases such as allergic asthma, allergic rhinitis, atopic dermatitis, anaphylaxis, and food and drug allergies are complex and cause a broad spectrum of symptoms ranging from mild to severe and potentially life-threatening anaphylactic reactions.

According to The Asthma and Allergy Foundation of America (AAFA), allergies are the 6th leading cause of chronic illness in the U.S. and each year more than 50 million Americans experience various types of allergies. Continuously rising cases of allergic diseases and other related medical conditions has fueled the global allergy diagnostics market.

Download a free sample report now 👉
https://meditechinsights.com/allergy-diagnostics-market/request-sample/

High Volume Consumption of Processed Food and Beverages Set to Spur the Food Allergen Testing Market

Food allergens continue to prevail as high-risk factors for the food production industry. The food allergen testing industry has garnered considerable traction globally because of high daily consumption of processed food and beverages. Allergens are a significant cause for concern in the global food processing industry. Food allergies which include abnormal reactions or hypersensitivity produced by the body’s immune system are considered a major food safety challenge. The food allergen testing market is anticipated to witness considerable momentum in the coming years due to the growth of the dairy, processed food and confectionary segments. Allergen detection tests are a key feature of allergen management systems in food processing plants and are executed at nearly every step of the process. These tests are carried out on work surfaces and products to detect any cross contamination or allergen presence and to test the effectiveness of a food processing unit’s cleaning measures.

Growing Prominence of mHealth in Allergy Diagnosis & Allergy Care

The widespread availability of technology-based interventions such as mobile health in the clinical setting has enabled patients to play an active role in their medical care. Mobile health (mHealth) utilizes mobile communication devices such as computers, tablets and smartphones to improve patient education & self-management of diseases, help in remote surveillance of patient health, the flow of data and information and disease management from first diagnosis to an optimized treatment.

The advent of patient-facing mHealth technologies (such as apps) is expected to favourably impact clinical, economic and process outcomes. Features such as medication reminders, educational content, games-based self-management, symptom diaries, electronic sensors, patient self-tracking dashboards, voice recognition, wearable technology, pollen sensors, and virtual reality offered by apps not only improve patient knowledge but also improve medication adherence, asthma and allergic conditions control, quality of life and results in fewer unscheduled office visits.

mHealth offers allergists and patients a new mode of communication via the phone camera, sound recording system, motion sensors, texting, and by using diagnostic devices and diagnostic algorithms incorporated in the smartphone itself.

Competitive Landscape Analysis

The global allergy diagnostics market is marked by the presence of established and emerging market players such as Thermo Fisher Scientific; Siemens Healthineers; Danaher Corporation; Omega Diagnostics Group PLC; NEOGEN Corporation; Canon Inc.; Eurofins Scientific; bioMérieux SA; Stallergenes Greer; and EUROIMMUN Medizinische Labordiagnostika AG among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Download a sample report for in-depth competitive insights
https://meditechinsights.com/allergy-diagnostics-market/request-sample/

Global Allergy Diagnostics Market Segmentation

This report by Medi-Tech Insights provides the size of the global allergy diagnostics market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product and service, allergen type, test type and end-user.

Market Size & Forecast (2023-2030), By Product and Service, USD Million

  • Consumables
  • Instruments
  • Services

Market Size & Forecast (2023-2030), By Allergen Type, USD Million

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Other Allergens

Market Size & Forecast (2023-2030), By Test Type, USD Million

  • In Vitro Tests
  • In Vivo Tests

Market Size & Forecast (2023-2030), By End-user, USD Million

  • Hospitals Laboratories
  • Diagnostic Laboratories
  • Academic & Research Institutions
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...
Post a Comment
Read more